ADAP
Adaptimmune Therapeutics plc
$0.18
-$0.00(-2.49%)
57
Overall
60
Value
58
Tech
55
Quality
Market Cap
$36.74M
Volume
36.73M
52W Range
$0.04 - $0.90
Target Price
$0.52
Key Metrics Overview
| Market Cap | $36.74M | P/E Ratio | N/A |
| 52W High | $0.90 | 52W Low | $0.04 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 33.5% | 52W Position | 16.3% |
| Overall Score | 57 | Value Score | 60 |
| Quality Score | 55 | Technical Score | 58 |
Growth Analysis
| EPS Current Est | $-0.48 | EPS Next Est | $-0.21 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADAP | $0.18 | -2.5% | 36.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Adaptimmune Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW